|
Note
9. Net Loss Per Share
Basic
and diluted net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of
shares of common stock outstanding during the period. Basic and diluted net loss per share is the same for all periods presented, as
the inclusion of potentially dilutive securities would have been anti-dilutive.
The
following potentially dilutive securities were excluded from the calculation of diluted net loss per share because their effect would
have been antidilutive:
Schedule
of Anti-dilutive Securities
| |
|
2026 |
|
|
2025 |
|
| |
|
Six months ended June 30,
|
|
| |
|
2026 |
|
|
2025 |
|
| Stock options |
|
|
1,076,312 |
|
|
|
24,012 |
|
| Warrants |
|
|
17,687 |
|
|
|
19,457 |
|
| Common shares issuable upon conversion of Series F Preferred Stock |
|
|
249,624 |
|
|
|
- |
|
| Common shares issuable upon conversion of warrants attached to Series H Preferred Stock |
|
|
23,925,000 |
|
|
|
- |
|
| Common shares issuable upon conversion of Series H Preferred Stock |
|
|
15,389,322 |
|
|
|
- |
|
| Total |
|
|
40,657,945 |
|
|
|
43,469 |
|
|